CA1120399A - Composes pharmaceutiques pour le traitement des cellules tumorales - Google Patents

Composes pharmaceutiques pour le traitement des cellules tumorales

Info

Publication number
CA1120399A
CA1120399A CA000336631A CA336631A CA1120399A CA 1120399 A CA1120399 A CA 1120399A CA 000336631 A CA000336631 A CA 000336631A CA 336631 A CA336631 A CA 336631A CA 1120399 A CA1120399 A CA 1120399A
Authority
CA
Canada
Prior art keywords
tumor
fatty acid
mono
disaccharide
tumor cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000336631A
Other languages
English (en)
Inventor
Vijai N. Nigam
Carlos A. Brailovsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Sherbrooke
Original Assignee
Universite de Sherbrooke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Sherbrooke filed Critical Universite de Sherbrooke
Priority to CA000336631A priority Critical patent/CA1120399A/fr
Application granted granted Critical
Publication of CA1120399A publication Critical patent/CA1120399A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000336631A 1979-09-28 1979-09-28 Composes pharmaceutiques pour le traitement des cellules tumorales Expired CA1120399A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000336631A CA1120399A (fr) 1979-09-28 1979-09-28 Composes pharmaceutiques pour le traitement des cellules tumorales

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000336631A CA1120399A (fr) 1979-09-28 1979-09-28 Composes pharmaceutiques pour le traitement des cellules tumorales

Publications (1)

Publication Number Publication Date
CA1120399A true CA1120399A (fr) 1982-03-23

Family

ID=4115240

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000336631A Expired CA1120399A (fr) 1979-09-28 1979-09-28 Composes pharmaceutiques pour le traitement des cellules tumorales

Country Status (1)

Country Link
CA (1) CA1120399A (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100382A1 (fr) * 1982-08-02 1984-02-15 Unitika Ltd. Nutriment intraveineux
EP0249008A2 (fr) * 1986-05-09 1987-12-16 Pulverer, Gerhard, Prof. Dr.Dr.h.c. Utilisation de monosaccharides spécifiques pour la préparation d'un médicament pour la prévention des métastases de tumeurs malignes
WO1996018632A1 (fr) * 1994-12-16 1996-06-20 Universite De Sherbrooke Procedes de preparation de series pures homologues de mono- a tetra-esters d'acyles gras de sucres; caracterisation d'un composant antitumoral en tant que tripalmitate 1, 6, 6' de maltose, et formulations pharmaceutiques utiles dans le traitement du cancer
WO2011110190A1 (fr) * 2010-03-08 2011-09-15 Romina Znoj Composé de cellobiose issu d'extraits de plantes ayant une activité apoptotique
EP2889035A4 (fr) * 2012-08-24 2016-07-13 Kakui Co Ltd Agent anti-tumoral

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100382A1 (fr) * 1982-08-02 1984-02-15 Unitika Ltd. Nutriment intraveineux
EP0249008A2 (fr) * 1986-05-09 1987-12-16 Pulverer, Gerhard, Prof. Dr.Dr.h.c. Utilisation de monosaccharides spécifiques pour la préparation d'un médicament pour la prévention des métastases de tumeurs malignes
EP0249008A3 (en) * 1986-05-09 1989-09-27 Gerhard Prof. Dr. Med. Pulverer Agent and process for the prevention of metastases of malignic tumours
WO1996018632A1 (fr) * 1994-12-16 1996-06-20 Universite De Sherbrooke Procedes de preparation de series pures homologues de mono- a tetra-esters d'acyles gras de sucres; caracterisation d'un composant antitumoral en tant que tripalmitate 1, 6, 6' de maltose, et formulations pharmaceutiques utiles dans le traitement du cancer
US5625044A (en) * 1994-12-16 1997-04-29 Goudreau Gage Dubec & Martineau Methods for the preparation of pure homologous series of mono to tetra fatty acyl esters of sugars and pharmaceutical formulations useful in the treatment of cancer
WO2011110190A1 (fr) * 2010-03-08 2011-09-15 Romina Znoj Composé de cellobiose issu d'extraits de plantes ayant une activité apoptotique
EP2889035A4 (fr) * 2012-08-24 2016-07-13 Kakui Co Ltd Agent anti-tumoral
CN106361757A (zh) * 2012-08-24 2017-02-01 可克意株式会社 抗肿瘤剂

Similar Documents

Publication Publication Date Title
US5225404A (en) Methods of treating colon tumors with tumor-inhibiting camptothecin compounds
AP231A (en) Antimalarial composition.
IL274444B2 (en) Chemokine receptor modulators for the treatment of Epstein-Barr virus-positive cancer
RU95122792A (ru) Фармацевтическая композиция с антиопухолевой активностью и способ ее получения, а также способ обработки раковых клеток человека
Webb et al. Antitumor effects of polynucleotides and theophylline
CA1093971A (fr) Compose carcinostatique et methode de traitement du cancer
JPH0390025A (ja) 抗腫瘍剤
Dembo et al. A randomized clinical trial of moving strip versus open field whole abdominal irradiation in patients with invasive epithelial cancer of the ovary
CA1120399A (fr) Composes pharmaceutiques pour le traitement des cellules tumorales
CA1038291A (fr) Methode et preparation pharmaceutique pour le traitement de l'hypercholesterolemie
Pronzato et al. Phase II study of lonidamine in metastatic breast cancer
DE3263832D1 (en) Gallium chloride, an anti-cancer drug
US3326761A (en) 6-demethyl-6-deoxytetracycline, anti-tumor antibiotic
Yron et al. Effects of methanol extraction residue and therapeutic irradiation against established isografts and simulated local recurrence of mammary carcinomas
Venditti et al. Chemotherapy of advanced mouse leukemia L1210: comparison of methotrexate alone and in sequential therapy
Ohkoshi et al. Clinical experience with a protease inhibitor [N, N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate for prevention of recurrence of carcinoma of the mouth and in treatment of terminal carcinoma
JPS57106618A (en) Anticancer agent consisting of polyprenyl compound
CN111558045A (zh) 一种治疗肺癌的药物组合物
US4444791A (en) Pharmaceutical composition and method for treating cachexia in humans due to cancer
US4725625A (en) Pharmaceutical composition and method for treating cachexia in humans due to cancer
KR920017653A (ko) 플루나리진을 함유하는 항종양제 조성물
Damia et al. Flavone acetic acid antitumour activity against a mouse pancreatic adenocarcinoma is mediated by natural killer cells
US3988447A (en) Pharmaceutical preparations
Sawada et al. Establishment of a new ovarian tumor line in nude mice and its application to treatment of the donor patient
Daghistani et al. Case report of successful use of VP‐16 in nasopharyngeal carcinoma

Legal Events

Date Code Title Description
MKEX Expiry